FDA opens applications for pilot program to shorten drug approval timelines
The FDA is accepting applications for a new pilot program designed to accelerate the timeline for drugmakers to begin human testing of their products.
How it unfolded
Every source in the order it published.
- STATSTAT+: FDA takes applications for new program to shorten drug approval times
- STATSTAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
- STATSTAT+: A Sellas immunotherapy study, long delayed, will end in failure
- STATSTAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more
- STATSTAT+: FDA has too few staffers to hire more staff
- STATSTAT+: New startup to test psychedelic-like drug against Parkinson’s symptom
- FortuneFormer White House economist: science has delivered a cancer detection revolution, now the FDA must keep pace
Sources
Every article we clustered into this story. Headlines link to the publisher.
- Former White House economist: science has delivered a cancer detection revolution, now the FDA must keep pace Fortune
- STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom STAT
- STAT+: FDA has too few staffers to hire more staff STAT
- STAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more STAT
- STAT+: A Sellas immunotherapy study, long delayed, will end in failure STAT
- STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more STAT
- STAT+: FDA takes applications for new program to shorten drug approval times STAT
In this story
- FDA
- Bavarian Nordic
- Sellas